Phase 4 Sickle Cell Disease Trial, Recruiting (NCT06979492)

Phase 4 Sickle Cell Disease Trial, Recruiting NCT06979492 Sponsor: Emory University Condition: Sickle Cell Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06979492 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sickle Cell Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are female
You have been diagnosed with sickle cell disease (any type, such as HbSS, HbSC, or HbSβ thalassemia)
You are 18 years of age or older
You are currently pregnant, between 6 and 20 weeks along
You are able to understand what the study involves and are willing to sign a consent form agreeing to take part
If you have private health insurance, your insurance company has given prior approval for blood transfusions

Who may not be able to join:

You were already receiving regular, scheduled blood transfusions before becoming pregnant
You have previously had a serious reaction to a blood transfusion called delayed hemolytic transfusion reaction (DHTR) with hyperhemolysis (confirm with trial site)
Your blood has antibodies that would make it very difficult to find suitable donor blood for transfusions
You are unable or unwilling to receive blood transfusions for personal, religious, or medical reasons
You are currently pregnant with triplets
You have a serious medical or mental health condition that, in your doctor's opinion, would prevent you from safely participating in a clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Ross Fasano, MD, Emory University

Phone: 404-712-5227

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06979492

Sponsor: Emory University

Phase: Phase 4

Status: Recruiting

Condition: Sickle Cell Disease

Trial contact: 404-712-5227

More information: https://clinicaltrials.gov/study/NCT06979492

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are female
You have been diagnosed with sickle cell disease (any type, such as HbSS, HbSC, or HbSβ thalassemia)
You are 18 years of age or older
You are currently pregnant, between 6 and 20 weeks along
You are able to understand what the study involves and are willing to sign a consent form agreeing to take part
If you have private health insurance, your insurance company has given prior approval for blood transfusions

Who may not be able to join:

You were already receiving regular, scheduled blood transfusions before becoming pregnant
You have previously had a serious reaction to a blood transfusion called delayed hemolytic transfusion reaction (DHTR) with hyperhemolysis (confirm with trial site)
Your blood has antibodies that would make it very difficult to find suitable donor blood for transfusions
You are unable or unwilling to receive blood transfusions for personal, religious, or medical reasons
You are currently pregnant with triplets
You have a serious medical or mental health condition that, in your doctor's opinion, would prevent you from safely participating in a clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Emory University

Registry

ClinicalTrials.gov

Start date

1 April 2026

Est. completion

1 May 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Hospital admissions rate; Number of maternal emergency department (ED)/Acute care visits; Number of SCD-related complications per group; Number of participants with pregnancy related complications; Maternal death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov